118 related articles for article (PubMed ID: 16301668)
1. Preferential targeting of CD4-CCR5 complexes with bifunctional inhibitors: a novel approach to block HIV-1 infection.
Mack M; Pfirstinger J; Haas J; Nelson PJ; Kufer P; Riethmüller G; Schlöndorff D
J Immunol; 2005 Dec; 175(11):7586-93. PubMed ID: 16301668
[TBL] [Abstract][Full Text] [Related]
2. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
3. Depletion of CCR5-expressing cells with bispecific antibodies and chemokine toxins: a new strategy in the treatment of chronic inflammatory diseases and HIV.
Brühl H; Cihak J; Stangassinger M; Schlöndorff D; Mack M
J Immunol; 2001 Feb; 166(4):2420-6. PubMed ID: 11160301
[TBL] [Abstract][Full Text] [Related]
4. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1.
Bouhlal H; Hocini H; Quillent-Grégoire C; Donkova V; Rose S; Amara A; Longhi R; Haeffner-Cavaillon N; Beretta A; Kaveri SV; Kazatchkine MD
J Immunol; 2001 Jun; 166(12):7606-11. PubMed ID: 11390517
[TBL] [Abstract][Full Text] [Related]
6. The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection.
Lehner T
Trends Immunol; 2002 Jul; 23(7):347-51. PubMed ID: 12103354
[No Abstract] [Full Text] [Related]
7. Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the in vitro effects on simian immunodeficiency virus or HIV infectivity.
Lehner T; Doyle C; Wang Y; Babaahmady K; Whittall T; Tao L; Bergmeier L; Kelly C
J Immunol; 2001 Jun; 166(12):7446-55. PubMed ID: 11390497
[TBL] [Abstract][Full Text] [Related]
8. A RANTES-antibody fusion protein retains antigen specificity and chemokine function.
Challita-Eid PM; Abboud CN; Morrison SL; Penichet ML; Rosell KE; Poles T; Hilchey SP; Planelles V; Rosenblatt JD
J Immunol; 1998 Oct; 161(7):3729-36. PubMed ID: 9759898
[TBL] [Abstract][Full Text] [Related]
9. Suppression of CCR5-tropic HIV type 1 infection by OX40 stimulation via enhanced production of β-chemokines.
Tanaka R; Takahashi Y; Kodama A; Saito M; Ansari AA; Tanaka Y
AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1147-54. PubMed ID: 20854204
[TBL] [Abstract][Full Text] [Related]
10. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs).
Agrawal L; Vanhorn-Ali Z; Alkhatib G
J Leukoc Biol; 2002 Nov; 72(5):1063-74. PubMed ID: 12429730
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CXCR4-tropic HIV-1 infection by lipopolysaccharide: evidence of different mechanisms in macrophages and T lymphocytes.
Verani A; Sironi F; Siccardi AG; Lusso P; Vercelli D
J Immunol; 2002 Jun; 168(12):6388-95. PubMed ID: 12055257
[TBL] [Abstract][Full Text] [Related]
12. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.
Mack M; Luckow B; Nelson PJ; Cihak J; Simmons G; Clapham PR; Signoret N; Marsh M; Stangassinger M; Borlat F; Wells TN; Schlöndorff D; Proudfoot AE
J Exp Med; 1998 Apr; 187(8):1215-24. PubMed ID: 9547333
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
[TBL] [Abstract][Full Text] [Related]
14. TNF-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes.
Hornung F; Scala G; Lenardo MJ
J Immunol; 2000 Jun; 164(12):6180-7. PubMed ID: 10843668
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of
Juno JA; Wragg KM; Kristensen AB; Lee WS; Selva KJ; van der Sluis RM; Kelleher AD; Bavinton BR; Grulich AE; Lewin SR; Kent SJ; Parsons MS
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867307
[TBL] [Abstract][Full Text] [Related]
16. Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection.
Kaur G; Tuen M; Virland D; Cohen S; Mehra NK; Münz C; Abdelwahab S; Garzino-Demo A; Hioe CE
Virology; 2007 Dec; 369(1):214-25. PubMed ID: 17765942
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates.
Lehner T; Wang Y; Cranage M; Tao L; Mitchell E; Bravery C; Doyle C; Pratt K; Hall G; Dennis M; Villinger L; Bergmeier L
Immunology; 2000 Apr; 99(4):569-77. PubMed ID: 10792505
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
19. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
20. RANTES and MCP-3 inhibit the replication of T-cell-tropic human immunodeficiency virus type 1 strains (SF-2, MN, and HE).
Schols D; Proost P; Van Damme J; De Clercq E
J Virol; 1997 Oct; 71(10):7300-4. PubMed ID: 9311806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
